|
29 Jun 2020 |
Rocket Pharmaceuticals Announces FDA Clearance of IND for RP-L401 Gene Therapy for Infantile Malignant Osteopetrosis
|
|
28 Jun 2020 |
Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Casimersen (SRP-4045) for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45
|
|
28 Jun 2020 |
Verve Therapeutics Presents New Data in Non-Human Primates Validating Gene Editing as a Treatment Approach for Coronary Heart Disease at the ISSCR 2020 Virtual Annual Meeting
|
|
26 Jun 2020 |
Artiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies to Treat Cancer
|
|
26 Jun 2020 |
Seelos Therapeutics Announces Initiation of Preclinical Study of SLS-007 in Parkinson's Disease
|
|
26 Jun 2020 |
Highlight Therapeutics announces first patient dosed in Phase IIa study in liver metastasis
|
|
26 Jun 2020 |
Nurix Therapeutics Announces Formation of DeCART Therapeutics to Advance New CAR T Therapies Using Targeted Protein Modulation
|
|
25 Jun 2020 |
Acceleron Presents Topline Results of the PULSAR Phase 2 Trial of Sotatercept in Patients with Pulmonary Arterial Hypertension
|
|
25 Jun 2020 |
uniQure Announces License Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy
|
|
24 Jun 2020 |
Medigene enters Phase I clinical development with its TCR-T immunotherapy MDG1021 in hematological cancers
|
|
23 Jun 2020 |
Medigene’s PD1-41BB Switch Receptor Enhances TCR-T Cell Activity Towards Solid Tumors
|
|
23 Jun 2020 |
Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AACR) Virtual 2020 Annual Meeting II
|
|
23 Jun 2020 |
miRagen Announces Encouraging Preclinical Safety and Efficacy Data for its Next-generation miR-29 Replacement Product Candidate Intended for the Treatment of Idiopathic Pulmonary Fibrosis
|
|
23 Jun 2020 |
Allogene Therapeutics Presents Preclinical Findings Supporting an Allogeneic DLL3 CAR for Small Cell Lung Cancer and Development of an Inducible TurboCAR™ at the American Association for Cancer Research (AACR) Virtual 2020 Meeting
|
|
23 Jun 2020 |
Century Therapeutics Announces Acquisition of Empirica Therapeutics
|
|
22 Jun 2020 |
Transgene Presents Promising New Data from its Next-Generation Immunotherapy Platforms at AACR 2020
|
|
22 Jun 2020 |
Transgene’s and BioInvent’s BT-001 Achieves Outstanding Tumor Cure Rates in Preclinical Models
|
|
20 Jun 2020 |
Catalyst Biosciences Presents Preclinical FIX Gene Therapy Data in an Oral Presentation at the World Federation of Hemophilia Virtual Summit 2020
|
|
20 Jun 2020 |
Finch Therapeutics Announces Positive Topline Results from Randomized Controlled Trial of CP101, an Oral Microbiome Drug, for the Prevention of Recurrent C. difficile Infection
|
|
19 Jun 2020 |
Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs
|
|
19 Jun 2020 |
Sanofi announces positive long-term efficacy and safety data for fitusiran from interim analysis of Phase 2 extension study in people with hemophilia A and B, with or without inhibitors
|
|
18 Jun 2020 |
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels and No Bleeding Events or Factor Usage in 3e13 vg/kg Cohort Following giroctocogene fitelparvovec (SB-525) Gene Therapy
|
|
17 Jun 2020 |
Armata Pharmaceuticals Announces $15 Million Award from the U.S. Department of Defense (DoD) for Development of Bacteriophage Therapy to Treat S. aureus Bacteremia Infections
|
|
17 Jun 2020 |
Atara Biotherapeutics Announces First Patient Enrolled in Randomized Placebo-Controlled Study of Allogeneic T-cell Therapy ATA188 in Progressive Forms of Multiple Sclerosis
|
|
16 Jun 2020 |
eTheRNA Raises EUR 34 Million in Series B Financing to Accelerate Multiple mRNA Therapeutic Development Programs Through to Clinical Proof of Concept
|
